2009 press releases
For more information or background, contact:
Charlie M. Mayr, Snr.
VP Corporate Affairs, Watson Pharmaceuticals, Inc.
Tel: +001 (862) 261 – 8030
Eden Biodesign Selected by Biotecnol SA for cGMP Production of Cardiotrophin-1 for Treatment of Life Threatening Liver Diseases
13 October 2009
13 October 2009
Eden Biodesign’s U.S. Technical Director to Present at the World Vaccine Congress in Lyon, France, October 7
29 September 2009
29 September 2009
Eden Biodesign selected by Omnio Healer AB for cGMP production of clinical trial product in wound healing and anti-infection
06 August 2009
06 August 2009
Eden Biodesign and Selexis Announce Continued Cooperation and a Global Joint-Marketing Collaboration
17 June 2009
17 June 2009
Eden Biodesign announces second successful MHRA Audit of its state-of-the-art cGMP manufacturing facility
12 May 2009
12 May 2009
Eden Biodesign's U.S. Technical Director to Present at 2009 BIO International Convention in May
21 April 2009
21 April 2009
Eden Biodesign's CEO, Dr Crawford Brown to speak at IBC's Non-Antibody Protein Therapeutics Development and Production Conference
25 February 2009
25 February 2009
To find out more information about Eden Biodesign, please contact us to request a copy of our brochure. If you would like one of our team to get in touch, please submit your details via our 
